财务信息 - 프로스테믹스
 
 

Balance Sheet - Settlement

Finance Label 2018 2017 2016
Price Composition Increase Price Composition Increase Price Composition Increase
total current assets 16,118 48.6% 16.2% 19,238 47% 33.8% 29,069 61.8% 0.9%
total non-current assets 17,034 51.4% 21.5% 21,699 53% 20.9% 17,948 38.2% 31.5%
total assets 33,153 100% 19% 40,937 100% 12.9% 47,017 100% 9.4%
total current liabilities 1,105 3.3% 4.1% 1,061 2.6% 41.3% 1,808 3.8% 41.6%
total non-current liabilities 206 .6% 11.9% 234 .6% 7% 219 .5% 91%
total liabilities 1,311 4% 1.2% 1,295 3.2% 36.1% 2,027 4.3% 45.2%
capital stocks 4,537 13.7% 0.5% 4,517 11% 0% 4,517 9.6% 4.1%
capital surplus 8,203 24.7% 2.9% 7,971 19.5% 75.8% 32,971 70.1% 20.1%
retained earnings 19,877 60% 25.6% 26,705 65.2% 498.6% 4,461 9.5% 145.9%
total stockholders' equity 31,842 96% 19.7% 39,642 96.8% 11.9% 44,990 95.7% 14.6%

Income Statement - Settlement

Finance Label 2018 2017 2016
Price Composition Increase Price Composition Increase Price Composition Increase
sales(net) 4,638 100% 23% 6,022 100% 57.8% 14,283 100% 2.1%
gross profit 1,527 32.9% 56.9% 3,540 58.8% 67.7% 10,965 76.8% 8%
operating income -4,736 -102.1% 14.4% -4,140 -68.7% 194.6% 4,375 30.6% 29.6%
non-operating income 662 14.3% 41.8% 467 7.8% 62.4% 1,241 8.7% 145.8%
non-operating expenses 1,598 34.5% 147.7% 645 10.7% 12.8% 572 4% 96%
net income -6,830 -147.3% 136.2% -2,892 -48% 164.2% 4,507 31.6% 154%

Cash Flow Statement - Settlement

Finance Label 2018 2017 2016
Price Increase Price Increase Price Increase
cash flows from operating activities -2,236 29.5% -3,174 150.8% 6,253 7.8%
cash flows from investing activities 185 97.9% 8,778 199.3% -8,839 79.5%
cf from financing act. 275 108.3% -3,307 0% 0 0%
increases(decreases) in cash -1,776 177.3% 2,297 188.8% -2,586 516.4%
cash at the beginning of the period 5,668 62.2% 3,495 41% 5,924 15.9%
cash at the end of the period 3,985 29.7% 5,668 62.2% 3,495 41%
简体中文